Breaking News

GenScript Unveils GenTitan Gene Fragments Service

Provides access to high-throughput, synthetic DNA for studies.

GenScript Biotech Corporation, a provider of life-science research tools and services, debuted its GenTitan Gene Fragments Synthesis service. The announcement was made at SynBioBeta 2023 in Oakland. Powered by GenScript’s innovative miniature semiconductor chip (MSC) technology, GenTitan propels gene synthesis to new heights for researchers worldwide, giving scientists from academia and industry access to high-throughput, synthetic DNA for their studies, and accelerating progress in the...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters